Fluorometholone
Flucon belongs to a group of medicinescalled corticosteroids. Their action is to prevent or reduce inflammation.
herpes simplex virus( herpes simplex). The patient should consult a doctor for advice if their condition worsens or does not improve.
Topical corticosteroid administration may be associated with decreased cortisol secretion in the urine as well as decreased cortisol levels in the blood. An association between corticosteroids and decreased growth rate in children has been observed, especially at high doses and with prolonged treatment. Before starting Flucon, the patient should discuss this with their doctor or pharmacist.
The safety of using Flucon in children under 3 years of age has not been established, so it is not recommended for this age group.
The patient should tell their doctor or pharmacist about all medicines they are currently taking or have recently taken, as well as any medicines they plan to take, including those available without a prescription. If the patient is using other eye drops or ointments, they should wait at least 5 minutes between administrations of the different medicines. Eye ointments should be used last.
Concurrent topical use of corticosteroids and non-steroidal anti-inflammatory drugs (NSAIDs) may increase the risk of eye healing problems. No interaction studies have been conducted.
When using eye drops intended to dilate the pupil (e.g., atropine), which can cause increased intraocular pressure, this effect may be enhanced when Flucon is used at the same time.
Corticosteroid eye medicines may cause increased intraocular pressure, reducing the effectiveness of glaucoma medicines.
Some medicines may enhance the effect of Flucon, so the doctor may decide to carefully monitor the patient's condition when taking these medicines (including certain HIV medicines: ritonavir, cobicistat).
If the patient is pregnant or breastfeeding, thinks they may be pregnant, or plans to have a child, they should consult a doctor or pharmacist before using this medicine.
Flucon has no or negligible influence on the ability to drive and use machines.
For a while after administering Flucon, vision may be blurred. The patient should not drive or operate machines until this symptom subsides .
The medicine contains 0.5 mg of benzalkonium chloride in every 5 milliliters of suspension, which corresponds to 0.1 mg/ml.
Benzalkonium chloride may be absorbed by soft contact lenses and change their color. The patient should remove contact lenses before administering the drops and wait at least 15 minutes before putting them back on.
Benzalkonium chloride may also cause eye irritation, especially in people with dry eye syndrome or corneal disorders (the transparent layer at the front of the eye). If abnormal sensations occur in the eye, stinging, or pain in the eye after using the medicine, the patient should contact a doctor.
Flucon eye drops contain 8.5 mg of monosodium phosphate monohydrate and 12.5 mg of disodium phosphate in every 5 milliliters of suspension, which corresponds to 2.8 mg of phosphates/ml.
In patients with severe damage to the transparent, anterior part of the eye (cornea), phosphates may, in very rare cases, cause corneal clouding due to calcium deposition during treatment.
This medicine should always be used as directed by the doctor.
If in doubt, the patient should consult a doctor or pharmacist.
If the protective cap is loosened after removing the cap, it should be discarded before using the medicine.
Adolescents and adults (including elderly patients)
The usual dose of Flucon is one drop into the eye or eyes, two to four times a day. During the first 24 to 48 hours, the doctor may increase the dosage to one drop every 4 hours. The doctor will inform how long the treatment will last.
Children
The safety of using Flucon in children under 3 years of age has not been established.
The doctor will determine how long to use the medicine.
If the medicine is used in patients with glaucoma, the treatment period should be limited to 2 weeks, unless longer treatment is justified.
Flucon is onlyintended for administration into the eye.
1
2
3
4
How to use the eye drops
This could cause infection of the drops.
If the drop does not get into the eye, the patient should try again to administer the drop correctly.
In case of accidental administration of an excessive amount of eye drops, the patient should rinse their eyes with lukewarm water. The patient should not use the medicine until the next scheduled dose.
If a dose of Flucon is missed, the patient should take the next scheduled dose. However, if it is almost time for the next dose, the missed dose should be skipped, and the patient should return to their regular dosing schedule. The patient should nottake a double dose to make up for the missed dose.
If the patient is using other eye drops or ointments, they should wait at least 5 minutes between administrations of the different medicines. Eye ointments should be used last.
If the patient has any further doubts about using this medicine, they should consult a doctor or pharmacist.
Like all medicines, Flucon can cause side effects, although not everybody gets them.
During treatment with Flucon eye drops, the following side effects have been observed with unknown frequency(the frequency of occurrence could not be determined from the available data):
Unless the side effects are severe, the patient can usually continue using the drops. If in doubt, the patient should consult a doctor or pharmacist.
If side effects occur, the patient should inform their doctor or pharmacist. This includes side effects not listed in this leaflet.
If side effects occur, including side effects not listed in the leaflet, the patient should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Adverse Reaction Monitoring of Medicinal Products, the Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products, Al.
Jerozolimskie 181C
02-222 Warsaw
Phone: +48 22 49 21 301
Fax: +48 22 49 21 309
Website: https://smz.ezdrowie.gov.pl
Reporting side effects will help gather more information on the safety of the medicine.
To prevent infections, the bottle should be discarded 28 days after it is first opened.
The date of opening the bottle should be written in the space provided below.
Date of first opening:………………
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The medicine should be stored out of sight and reach of children.
Do not store above 25°C.
Do not store in the refrigerator.
Do not freeze.
Store the container tightly closed.
The expiration date is the last day of the specified month.
Flucon is a liquid (suspension, white to light brown) in a 5 ml plastic bottle with a dropper made of low-density polyethylene with a polypropylene cap. The carton contains 1 bottle of 5 ml.
For more detailed information, the patient should contact the marketing authorization holder or parallel importer.
Immedica Pharma AB
Solnavägen 3H
113 63 Stockholm
Sweden
Novartis Pharma GmbH
Roonstrasse 25
90429 Nuremberg
Germany
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
CEFEA Sp. z o.o. Sp. komandytowa
ul. Działkowa 56
02-234 Warsaw
Pharma Innovations Sp. z o.o.
ul. Jagiellońska 76
03-301 Warsaw
Synoptis Industrial Sp. z o.o.
ul. Szosa Bydgoska 58
87-100 Toruń
IVA Pharm Sp. z o.o.
ul. Drawska 14/1
02-202 Warsaw
CANPOLAND SPÓŁKA AKCYJNA
ul. Beskidzka 190
91-610 Łódź
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Number of the marketing authorization in Greece, the country of export: 47840/14-10-2008
Number of the parallel import authorization: 71/21
[Information about the trademark]
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.